( October 15, 2025, 12:34 PM EDT) -- CAMDEN, N.J. — A federal judge in New Jersey dismissed investors’ class action complaint alleging a drug design company, its former CEO and former chairman of the board violated federal securities laws by not disclosing the former CEO’s and chairman’s misconduct in public filings about the company’s code of conduct and its fostering of an inclusive workplace, finding that most of the challenged statements were inactionable puffery and that the company’s failure to disclose the misconduct did not render the statements misleading....